1. Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza — United States, 2021–22 Influenza Season
- Author
-
Adams, Katherine, Tastad, Katie J, Huang, Stacy, Ujamaa, Dawud, Kniss, Krista, Cummings, Charisse, Reingold, Arthur, Roland, Jeremy, Austin, Elizabeth, Kawasaki, Breanna, Meek, James, Yousey-Hindes, Kimberly, Anderson, Evan J, Openo, Kyle P, Reeg, Libby, Leegwater, Lauren, McMahon, Melissa, Bye, Erica, Poblete, Mayvilynne, Landis, Zachary, Spina, Nancy L, Engesser, Kerianne, Bennett, Nancy M, Gaitan, Maria A, Shiltz, Eli, Moran, Nancy, Sutton, Melissa, Abdullah, Nasreen, Schaffner, William, Talbot, H Keipp, Olsen, Kristen, Staten, Holly, Taylor, Christopher A, Havers, Fiona P, Reed, Carrie, Budd, Alicia, Garg, Shikha, O’Halloran, Alissa, and Brammer, Lynnette
- Subjects
Influenza ,Pediatric ,Immunization ,Infectious Diseases ,Biodefense ,Emerging Infectious Diseases ,Vaccine Related ,Prevention ,Lung ,Pneumonia & Influenza ,Infection ,Good Health and Well Being ,Child ,Humans ,Adolescent ,United States ,SARS-CoV-2 ,Influenza ,Human ,Coinfection ,Seasons ,Prevalence ,COVID-19 ,Death ,General & Internal Medicine - Abstract
The 2022-23 influenza season shows an early rise in pediatric influenza-associated hospitalizations (1). SARS-CoV-2 viruses also continue to circulate (2). The current influenza season is the first with substantial co-circulation of influenza viruses and SARS-CoV-2 (3). Although both seasonal influenza viruses and SARS-CoV-2 can contribute to substantial pediatric morbidity (3-5), whether coinfection increases disease severity compared with that associated with infection with one virus alone is unknown. This report describes characteristics and prevalence of laboratory-confirmed influenza virus and SARS-CoV-2 coinfections among patients aged
- Published
- 2022